glass onion new york company limited liability company

729 seventh avenue
12th floor
new york, new york 10019

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 31, 2014

NYS DOS ID#
4615371

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - GLASS ONION NEW YORK COMPANY LIMITED LIABILITY COMPANY









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Woody Allen’s ‘Wonder Wheel’ set to close NY Film Festival
    By Deadline - Tuesday Jul 25, 2017

    The film will go into limited release December 1.

    Source: New York Post: Entertainment
  • NY insurance company dragged into Wells Fargo scandal
    By Kevin Dugan - Tuesday Aug 1, 2017

    The New York insurance company that wrote policies for 800,000 questionable Wells Fargo auto loans has been dragged into the bank’s latest scandal. National General Insurance was named in a class-action lawsuit filed against the bank — for allegedly unduly profiting from $80 million in collateral protection insurance that the drivers didn’t need — and...

    Source: New York Post: Business
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • NY Times sees jump in digital subscription revenue
    By Reuters - Thursday Jul 27, 2017

    The New York Times said on Thursday its digital subscription revenue overtook print advertising revenue for the first time — a key milestone in the 166-year old publisher’s efforts to transform itself into a digital media powerhouse. The company’s shares rose as much as 7 percent to their highest since the 2008 financial crisis as...

    Source: New York Post: Business
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
glass onion new york company limited liability company new york ny